FibroBiologics (FBLG) News Today $0.53 -0.01 (-1.80%) Closing price 04:00 PM EasternExtended Trading$0.53 +0.00 (+0.47%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBLG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period FibroBiologics' (FBLG) "Buy" Rating Reiterated at HC WainwrightSeptember 15 at 3:07 AM | americanbankingnews.comFibroBiologics publishes opinion editorial on stem cell therapiesSeptember 12, 2025 | msn.comFibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell TherapiesSeptember 12, 2025 | globenewswire.comFibroBiologics announces IND-enabling updates from psoriasis research programSeptember 11, 2025 | msn.comFibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis TreatmentSeptember 11, 2025 | globenewswire.comFibroBiologics' (FBLG) Buy Rating Reaffirmed at D. Boral CapitalSeptember 11, 2025 | americanbankingnews.comFBLG: Advancing Bone Marrow Organoid Platform for Cancer and Immune-Related Therapies…September 10, 2025 | finance.yahoo.comFibroBiologics announces advancements in Bone Marrow Organoid platformSeptember 10, 2025 | msn.comFibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related TherapiesSeptember 10, 2025 | globenewswire.comFibroBiologics (FBLG) & Its Rivals Head-To-Head ReviewSeptember 9, 2025 | americanbankingnews.comFibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 27, 2025 | globenewswire.comFBLG: Closes Third Tranche of $5M…August 5, 2025 | msn.comFibroBiologics, Inc.: FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 1, 2025 | finanznachrichten.deFibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateJuly 31, 2025 | globenewswire.comFibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical ApplicationsJuly 28, 2025 | globenewswire.comBrag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVJuly 11, 2025 | usatoday.comFibroBiologics to Present at the Advanced Wound Care Summit USAJuly 11, 2025 | globenewswire.comFibroBiologics Confirms Ability to Manufacture CybroCell™ for ...July 10, 2025 | finance.yahoo.comFibrobiologics Confirms Ability to Manufacture Cybrocell for Degenerative Disc Disease and Cartilage Repair Programs from Existing Cywc628 Master Cell BankJuly 9, 2025 | marketscreener.comMFibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell BankJuly 9, 2025 | globenewswire.comFibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10July 7, 2025 | finance.yahoo.comFibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10July 7, 2025 | globenewswire.comFibroBiologics, Inc. (FBLG) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comFibroBiologics to Present Company Update and Research Advances at BIO International Convention 2025June 17, 2025 | nasdaq.comFibroBiologics Secures $5M in Equity Purchase AgreementJune 16, 2025 | tipranks.comFibroBiologics Closes Third $5 Million Tranche of $25 Million FinancingJune 16, 2025 | globenewswire.comFibroBiologics to Present at the BIO International Convention 2025June 16, 2025 | globenewswire.comFibroBiologics, Inc. Holds Annual Stockholders MeetingJune 13, 2025 | tipranks.comFibroBiologics Appoints Jason D. Davis as CFOJune 9, 2025 | tipranks.comFibrobiologics, Inc.: FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial OfficerJune 9, 2025 | finanznachrichten.deFibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial OfficerJune 9, 2025 | globenewswire.comFibroBiologics, Inc. (NASDAQ:FBLG) Insider Hamid Khoja Purchases 20,000 SharesMay 28, 2025 | insidertrades.comFBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis…May 22, 2025 | msn.comPromising Potential for FibroBiologics, Inc. in Regenerative Medicine with Innovative Fibroblast-Based TherapiesMay 17, 2025 | tipranks.comFibroBiologics Presents at the Society for Investigative Dermatology Annual MeetingMay 16, 2025 | globenewswire.comFibrobiologics, Inc.: FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 15, 2025 | finanznachrichten.deFibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comFibroBiologics Says Robert Hoffman to Step Down as Interim CFOMay 5, 2025 | marketwatch.comFibroBiologics Presenting at the ThymUS 2025 MeetingApril 29, 2025 | globenewswire.comFibroBiologics to Present at The Cell & Gene Meeting on the MediterraneanApril 11, 2025 | globenewswire.comOTC Markets Hosts Virtual Investor Presentation with Pete O'Heeron, CEO & Chairman of FibroBiologics, Inc., with David Bautz, PhD, Senior Analyst at Zacks SCRApril 9, 2025 | msn.comFibroBiologics announces opening of new lab facilityApril 8, 2025 | markets.businessinsider.comFibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based TherapeuticsApril 8, 2025 | globenewswire.comFibroBiologics Reports 2024 Financial Results and UpdatesApril 3, 2025 | tipranks.comFBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…April 3, 2025 | finance.yahoo.comFibroBiologics announces advancement in results of brain tissue repairApril 2, 2025 | markets.businessinsider.comFibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue RepairApril 2, 2025 | globenewswire.comFibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 31, 2025 | globenewswire.comFibroBiologics Announces 2025 Annual Meeting of StockholdersMarch 27, 2025 | globenewswire.comFibroBiologics to Present at The German-Nordic Joint Extracellular Matrix MeetingMarch 21, 2025 | globenewswire.com Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FBLG Media Mentions By Week FBLG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBLG News Sentiment▼0.040.92▲Average Medical News Sentiment FBLG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBLG Articles This Week▼122▲FBLG Articles Average Week Get the Latest News and Ratings for FBLG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for FibroBiologics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ANIX News Today ALTS News Today VIRI News Today ENTX News Today ORMP News Today CRDL News Today ATRA News Today STRO News Today XBIT News Today ARTV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBLG) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
